LMRI — Lumexa Imaging Holdings Income Statement
0.000.00%
Last trade - 00:00- $1.02bn
- $2.25bn
- $948.87m
- 13
- 42
- 29
- 16
Annual income statement for Lumexa Imaging Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 936 | 949 |
| Cost of Revenue | ||
| Gross Profit | 99 | 96.3 |
| Selling / General / Administrative Expenses | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 913 | 892 |
| Operating Profit | 22.4 | 56.8 |
| Total Net Non Operating Interest Income / Expense | ||
| Net Income Before Taxes | -119 | -79.2 |
| Provision for Income Taxes | ||
| Net Income After Taxes | -122 | -94.1 |
| Net Income Before Extraordinary Items | ||
| Net Income | -122 | -94.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -122 | -94.1 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -1.15 | -1.01 |